Tumor Lysis Syndrome

Overview

4.8 out of 5 (70 Reviews)

Credits

1.50

Post Assessment Questions

10

Start Date

1 Sep 2023

Last Review Date

5 Oct 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6629 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7872.5 hours of CE.

Single Activity

Take this single activity

$43.50 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$139 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Tumor lysis syndrome is a critical medical condition that arises from the rapid breakdown of tumor cells, leading to significant metabolic disturbances such as hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia. These disturbances can result in severe complications, including acute kidney injury, cardiac arrhythmias, and even death. Tumor lysis syndrome is commonly observed in patients undergoing treatment for hematologic malignancies such as non-Hodgkin lymphomas, acute leukemias, and Burkitt lymphoma, particularly following the initiation of chemotherapy. However, tumor lysis syndrome may also occur spontaneously.

Patients at high risk of developing tumor lysis syndrome typically have neoplasms with a high proliferative rate and significant sensitivity to chemotherapy. Prevention and early intervention are crucial. Strategies include aggressive hydration; the use of hypouricemic agents, such as allopurinol or rasburicase; and close monitoring of metabolic parameters. Timely recognition and management of tumor lysis syndrome are essential to reducing patient morbidity, emphasizing the importance of vigilant monitoring during cancer treatment. This activity reviews the epidemiology, pathophysiology, identification, evaluation, and management of tumor lysis syndrome, highlighting the role of the interprofessional team in improving outcomes for patients with this life-threatening disease condition.


UAN: JA4008338-0000-23-4653-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify patients at risk for developing tumor lysis syndrome based on their clinical history.

  • Select interventions for patients with tumor lysis syndrome to prevent or mitigate end-organ injury and failure.

  • Apply best practices to reduce the incidence of tumor lysis syndrome in high-risk patients.

  • Implement interprofessional team strategies to improve care coordination and outcomes in patients with tumor lysis syndrome.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.50 ACPE credit(s). (UAN: JA4008338-0000-23-4653-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Sara C. on 3/31/2021

Lisa S. on 8/21/2021

Lorrie E. on 10/8/2021

Stephanie H. on 10/14/2021

Timothy M. on 2/16/2022

Diane L. on 2/18/2022

Danna M. on 3/16/2022

Halyna H. on 3/21/2022

Dorthya D. on 3/26/2022

Abbas A. on 4/25/2022

John M. on 5/5/2022

Anne C. on 5/9/2022

Ali O. on 5/24/2022

Denise D. on 6/9/2022

Eliseo J. on 7/22/2022

Vonda R. on 8/19/2022

Samantha h. on 8/28/2022

Elena N. on 9/11/2022

Angela H. on 10/2/2022

Brea M. on 10/3/2022

none

Tamatha J. on 10/4/2022

Casilda v. on 10/10/2022

Denise B. on 10/12/2022

Deanne N. on 12/18/2022

Erica I. on 12/28/2022

Ravi J. on 2/1/2023

Michael B. on 3/5/2023

Jennifer C. on 3/5/2023

Theresa C. on 3/9/2023

John B. on 3/26/2023

Melanie P. on 3/18/2023

DHANARAJA PADUBIDRI D. on 4/22/2023

Ronald D. on 5/10/2023

Stephani R. on 6/26/2023

Amanda H. on 6/30/2023

Ashley W. on 7/1/2023

Waldo F. on 7/25/2023

Edgardo R. on 7/22/2023

Kelly K. on 8/16/2023

melody p. on 9/2/2023

kerry k. on 9/6/2023

Cheryl K. on 9/15/2023

Sonya D. on 9/15/2023

Dr Sruthi G. on 9/27/2023

Tanya H. on 9/30/2023

Thanks

Matthew C. on 10/2/2023

Jennifer N. on 10/2/2023

Kayci H. on 10/26/2023

sandra a. on 11/3/2023

Samantha P. on 11/11/2023

alexandria g. on 11/25/2023

Rakesh M. on 12/14/2023

Linda G. on 12/17/2023

Raymond S. on 12/19/2023

James T. on 12/27/2023

Ehsan Q. on 1/10/2024

Wassim E. on 2/16/2024

Jonathan A. on 2/17/2024

Gardenia Z. on 3/9/2024

Hawabu S. on 3/25/2024

John B. on 3/29/2024

on 4/1/2024

DHANARAJA PADUBIDRI D. on 8/28/2024

Kathryn L. on 9/4/2024

Florence Y. on 9/23/2024

hector L. on 9/29/2024

Roxana R. on 10/1/2024

Jean B. on 10/12/2024

Karen M. on 10/20/2024

Timothy S. on 11/8/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6629 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7872.5 hours of CE.

Single Activity

Take this single activity

$43.50 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$139 per 1 year per user